期刊文献+

胃癌患者营养状况与TNF-α IL-6 IFN-γ的相关性研究 被引量:9

Correlation on nutrition status of patients with gastric cancer and TNF-α,IL-6 and IFN-γ
下载PDF
导出
摘要 目的探讨胃癌患者营养状况与肿瘤坏死因子(TNF-α)、白介素-6(IL-6)、干扰素-γ(IFN-γ)的关系。方法运用流式细胞小球微阵列术(CBA)对胃癌术前患者(胃癌组)40例和健康体检者(对照组)30例的TNF-α、IL-6、IFN-γ水平进行检测,结合临床及病理资料,分析上述指标与胃癌患者营养状况的关系。结果与对照组相比,胃癌组和有营养风险的胃癌患者TNF-α、IL-6、IFN-γ表达水平增高,差异均有统计学意义(P<0.05)。基于胃癌患者、有营养风险胃癌患者不同性别、病理类型、临床分期的分析中,TNF-α、IL-6的表达水平差异均无统计学意义(P>0.05),而胃癌患者中TNF-α与IL-6、IFN-γ显著相关,IL-6与IFN-γ显著相关。结论 TNF-α、IL-6、IFN-γ表达水平与胃癌患者营养状况有关,与性别、病理类型、临床分期无关;TNF-α、IL-6、IFN-γ可作为早期诊断胃癌营养不良的参考指标。 Objective To explore the correlation between nutrition status of patients with gastric cancer and TNF-a, IL-6 and IFN-7. Methods Cytometric Bead Array (CBA) was applied to determine TNF-a, IL-6 and IFN-7 level of gastric cancer group (40 cases) and control group(30 cases). The relationship between nutrition status of patients with clinical and pathological data were analyzed. Results The expression level of TNF-a, IL-6 and IFN-yof gastric cancer group and gastric cancer group of nutritional risk were significantly higher than that of control group (P〈0.05). The expression level of TNF-a and IL-6 of patients with gastric cancer with different genders, pathological patterns and clinical stages were not statistical significant different (P〉0.05). The IL-6 and TNF-a, IFN-y among patients with gastric cancer were significant correlated. TNF-a and IFN-y were significant correlated. Conclusion TNF-a, IL-6, IFN-y are related with occurrence of malnutrition with patients with gastric cancer. The aforementioned factors can be used to assist the determination of nutritional status of patients with gastric cancer.
出处 《西部医学》 2016年第9期1238-1242,共5页 Medical Journal of West China
基金 云南省卫生科技计划项目(2012WS0036)
关键词 胃癌 营养状况 细胞因子 Stomach neoplasms Nutritional statusl Cytokine
  • 相关文献

参考文献19

  • 1Ferlay J,Shin H,Bray Y,etal,Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
  • 2于颖彦.胃癌的病理分型与预后[J].外科理论与实践,2011,16(3):240-243. 被引量:22
  • 3Murphy KT,Lynch GS.Editorial update on emerging drugs for cancer cachexia [J].Expert opinion on emerging drugs,2012,17(1):5-9.
  • 4Palesty J,Dudrick S.What we have learned about cachexia in gastro- intestinal cancer [J].Digestive diseases,2003,21(3):198-213.
  • 5Kern KA,Norton JA.Cancer cachexia [J].JPEN J Parenter En- teral Nutr,1988,12(3):286-298.
  • 6杨焕东,张春梅.胃肠道肿瘤患者血清瘦素和肿瘤坏死因子水平与营养状态的关系[J].中国临床保健杂志,2009,12(2):177-178. 被引量:5
  • 7Opden Kamp CM,Langen RC,Minnaard K,et al.Pre-cachexia in patients with stages Ⅰ-Ⅲ non-small cell lung cancer:systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system [J].Lung Cancer,2012,76(1):112-117.
  • 8Alter J,Rozentzweig D,Bengal E.Inhibition of myoblast differ- entiation by tumor necrosis factor a is mediated by c-Jun N-ter- minal kinase I and leukemia inhibitory factor [J].J Biol Chem,2008,283(34):23224-23234.
  • 9Correia M,Cravo M,Marques-Vidal P,et al.Serum concentra- tions of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer [J],Clin Nu- tr,2007,26(6):728-735.
  • 10Torelli GF,Meguid MM,Moldawer LL,et al.Use of recombi- nant human soluble TNF receptor in anorectic tumor-bearing rats [J].American Journal of Physiology-Regulatory,Integrative and Comparative Physiology,1999,277(3):R850-R855.

二级参考文献47

  • 1刘爱国,李同度.癌症恶病质研究进展[J].癌症进展,2003,1(2):126-130. 被引量:7
  • 2周张章,周才琼,赵国华,阚健全.瘦素与肥胖的关系[J].中国临床保健杂志,2005,8(1):85-87. 被引量:5
  • 3宋衍秋,夏大胜.瘦素与冠心病[J].中国心血管杂志,2005,10(2):144-146. 被引量:13
  • 4李景武,梁寒,王晓娜.814例胃癌患者的预后因素分析[J].中国肿瘤临床,2006,33(7):399-402. 被引量:37
  • 5Bozzetti F, Migliavacca S, Scotti A, et al. Impact of cancer, type, site, stage and treatment on the nutritional status of patients [ J ]. Ann Surg,1982,196 (2) :170-179.
  • 6Eduardo B,Catherine S. Cachexia and asthenia in cancer patients [ J]. The Lancet Oncology,2000,1 ( 1 ) : 138-147.
  • 7DeWys WD, Egg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients [ J ]. Am J Med, 1980,69(4) :491-497.
  • 8McMillan DC, Watson WS, O Gorman P, et al. Albumin Concentrations are primarily determined by the body cell mass and systemic inflammatory response in cancer patients with weight loss [J]. Nutr Cancer,2001,39(2) :210-213.
  • 9Fearon KC,Preston T. Body composition in cancer cachexia[ J]. Infusionstherapie, 1990,17 ( 3 ) :63-66.
  • 10Kotler DP,Tierney AR, Francisco A, et al. The magnitude of body cell mass depletion determines the timing of death from wasting in AIDS[ J]. Am J Clin Nutr, 1989,50(3 ) :444-447.

共引文献30

同被引文献89

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部